Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study
出版年份 2016 全文链接
标题
Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study
作者
关键词
-
出版物
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume 41, Issue 3, Pages 290-297
出版商
Wiley
发表日期
2016-04-25
DOI
10.1111/jcpt.12391
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
- (2014) Tatsuo Hosoya et al. Clinical and Experimental Nephrology
- Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension
- (2014) Masanari Kuwabara et al. HYPERTENSION RESEARCH
- Hyperuricemia Is a Significant Risk Factor for the Onset of Chronic Kidney Disease
- (2014) Akiko Toda et al. NEPHRON CLINICAL PRACTICE
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
- (2012) Yanyan Zhu et al. AMERICAN JOURNAL OF MEDICINE
- An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan
- (2012) Naoyuki Kamatani et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Prevalence of and Factors Associated with Chronic Kidney Disease (CKD) in Japanese Subjects without Notable Chronic Diseases, Undergoing an Annual Health Checkup
- (2012) Yoshiteru Ohno et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
- (2011) Yanyan Zhu et al. ARTHRITIS AND RHEUMATISM
- Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders
- (2011) Juan G. Puig et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan
- (2011) SHENGFENG WANG et al. NEPHROLOGY
- Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study
- (2011) Masatoshi Kawashima et al. BMC Nephrology
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- FYX-051: A Novel and Potent Hybrid-Type Inhibitor of Xanthine Oxidoreductase
- (2010) K. Matsumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia
- (2009) Takahiro Sato et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Points to consider on switching between superiority and non-inferiority
- (2002) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started